WARNING: This product is for research use only, not for human or veterinary use.
MedKoo CAT#: 406626
Description: CEP-14513 is a potent ALK inhibitor. CEP-14513 displayed potent ALK inhibitory activity in both in vitro enzymatic assay (IC50 = 5 nM) and cell-based assays of ALK tyrosine phosphorylation (IC50 = 30 nM).
MedKoo Cat#: 406626
Chemical Formula: C34H36N6O3
Exact Mass: 576.28489
Molecular Weight: 576.69
Elemental Analysis: C, 70.81; H, 6.29; N, 14.57; O, 8.32
CEP-14513 is not in stock, may be available through custom synthesis. For cost-effective reason, minimum 1 gram order is requested. The product will be characterized by NMR, HPLC and MS analysis. Purity (HPLC) is usually >98%. CoA, QC data, MSDS will be provided when product is successfully made. The estimated lead time is 2-3 months. Please send email to firstname.lastname@example.org to inquire quote.
Synonym: CEP14513; CEP 14513; CEP-14513.
IUPAC/Chemical Name: 13-isobutyl-4-methyl-6-oxo-2,4,6,7,8,13-hexahydro-1H-indazolo[5,4-a]pyrrolo[3,4-c]carbazol-10-yl 4-(dimethylamino)benzylcarbamate
InChi Key: ZFKJDNACAGAYFJ-UHFFFAOYSA-N
InChi Code: InChI=1S/C34H36N6O3/c1-19(2)17-40-28-13-10-22(43-34(42)36-15-20-6-8-21(9-7-20)38(3)4)14-24(28)30-25-16-35-33(41)31(25)29-23(32(30)40)11-12-27-26(29)18-39(5)37-27/h6-10,13-14,18-19H,11-12,15-17H2,1-5H3,(H,35,41)(H,36,42)
SMILES Code: O=C(OC1=CC=C(N(CC(C)C)C2=C3C4=C(C(NC4)=O)C5=C2CCC6=NN(C)C=C65)C3=C1)NCC7=CC=C(N(C)C)C=C7
The following data is based on the product molecular weight 576.69 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||1.15 mL||5.76 mL||11.51 mL|
|5 mM||0.23 mL||1.15 mL||2.3 mL|
|10 mM||0.12 mL||0.58 mL||1.15 mL|
|50 mM||0.02 mL||0.12 mL||0.23 mL|
1. Haack, H.; Crosby, K. E.; Rimkunas, V. M.; Silver, M. R. Anaplastic lymphoma kinase in kidney cancer. WO2012019132A2.